Docket Room
HB 466·DE·house

AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO THE APPLICATION OF NASAL EPINEPHRINE.

Signed into LawFiled Jun 4, 2026
Sponsor: DeShanna Neal (D)
Latest Action

Signed by Governor

Jul 23, 2026

Summary

The bill amends the state health code so that public and private institutions of higher education may obtain epinephrine autoinjectors and intranasal sprays under a prescription in the school's name and keep them in an accessible location. Trained campus staff can then give or administer the medication to anyone showing signs of anaphylaxis, regardless of whether the person has a prescription. The Department of Health is tasked with promoting safe use and issuing implementing regulations.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Share

Track this bill

Get real-time alerts when HB 466 changes status, plus AI-powered summaries and stage predictions.

Sign up free
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice